Literature DB >> 29848678

MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.

Nan-Hua Chou1, Yi-Hao Lo2, Kuo-Chiang Wang1, Chi-Hsiang Kang1, Chung-Yu Tsai1, Kuo-Wang Tsai3,4,5.   

Abstract

BACKGROUND/AIM: MicroRNAs (miRNAs) are small non-protein-coding RNAs, that can be generated from the 5p or 3p arm of precursor miRNA (pre-miRNA). Differential miRNA arm selection has been reported between tumor and normal tissue in many cancer types; however, the biological function and mechanism of miRNA arm switching in gastric cancer remain unclear.
MATERIALS AND METHODS: Profiles of miRNA expression in gastric cancer were obtained from The Cancer Genome Atlas (TCGA). The biological role of miR-193a-5p/-3p in tumor growth and invasive abilities was assessed through a gain-of-function approach. Target genes of miR-193a-3p were identified using bioinformatics and an experimental approach.
RESULTS: The expression levels of miR-193a-5p, and not of miR-193a-3p, were significantly decreased in gastric cancer compared to adjacent normal tissues. Ectopic expressions of miR-193a-5p and miR-193a-3p revealed that they both inhibited gastric cancer cell growth, but only miR-193a-3p significantly suppressed cell invasion ability. Using a bioinformatics approach, we identified 18 putative target genes of miR-193a-3p. Both mRNA and protein levels of cyclin D1 (CCND1) and ETS proto-oncogene 1 (ETS1) were significantly decreased in AGS cells transfected with miR-193a-3p mimics. ETS1 or CCND1 knockdown significantly suppressed gastric cancer cell growth, similar to miR-193a-3p overexpression.
CONCLUSION: Our results indicated that miR-193a-3p suppressed gastric growth and motility, at least partly, by directly targeting CCND1 and ETS1 expression. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  CCND1; ETS1; arm selection; gastric cancer; miR-193a

Mesh:

Substances:

Year:  2018        PMID: 29848678     DOI: 10.21873/anticanres.12596

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  21 in total

1.  Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis.

Authors:  Haifang Wang; Wenxiang Chen; Peng Yang; Jun Zhou; Kaiyuan Wang; Qingchun Tao
Journal:  Cancer Biol Ther       Date:  2018-11-07       Impact factor: 4.742

Review 2.  Stabilization of miRNAs in esophageal cancer contributes to radioresistance and limits efficacy of therapy.

Authors:  Akshay Malhotra; Uttam Sharma; Shyamly Puhan; Naga Chandra Bandari; Anjali Kharb; P P Arifa; Lovlesh Thakur; Hridayesh Prakash; Karen M Vasquez; Aklank Jain
Journal:  Biochimie       Date:  2018-10-13       Impact factor: 4.079

3.  Lysine demethylase 5A promotes prostate adenocarcinoma progression by suppressing microRNA-330-3p expression and activating the COPB2/PI3K/AKT axis in an ETS1-dependent manner.

Authors:  Yuanyuan Mi; Lifeng Zhang; Chuanyu Sun; Yanyan Feng; Jian Sun; Jun Wang; Dongjie Yang; Xiaowei Qi; Hongyuan Wan; Guowei Xia; Sheng Wu; Lijie Zhu
Journal:  J Cell Commun Signal       Date:  2022-05-18       Impact factor: 5.782

4.  Exosomal mir-625-3p derived from hypoxic lung cancer cells facilitates metastasis by targeting SCAI.

Authors:  Yi Zhang; Kun Qian; Xingsheng Liu; Xin Zhao; Teng Zhao; Gaojun Lu
Journal:  Mol Biol Rep       Date:  2022-08-21       Impact factor: 2.742

5.  Knockdown of SNHG16 suppresses the proliferation and induces the apoptosis of leukemia cells via miR‑193a‑5p/CDK8.

Authors:  Meihua Piao; Li Zhang
Journal:  Int J Mol Med       Date:  2020-07-08       Impact factor: 4.101

6.  Downregulation of miR‑193a‑3p via targeting cyclin D1 in thyroid cancer.

Authors:  Xiao-Jiao Li; Rong Wen; Dong-Yue Wen; Peng Lin; Deng-Hua Pan; Li-Jie Zhang; Yu He; Lin Shi; Yong-Ying Qin; Yun-Hui Lai; Jing-Ni Lai; Jun-Lin Yang; Qin-Qiao Lai; Jun Wang; Jun Ma; Hong Yang; Yu-Yan Pang
Journal:  Mol Med Rep       Date:  2020-07-08       Impact factor: 2.952

7.  miR-1 inhibits the proliferation of breast cancer stem cells by targeting EVI-1.

Authors:  Lei Wu; Tianyi Wang; Dongning He; Xiaoxi Li; Youhong Jiang
Journal:  Onco Targets Ther       Date:  2018-12-06       Impact factor: 4.147

8.  Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated 188Rhenium-Mediated Suppression of Orthotopic Hypopharyngeal Tumor.

Authors:  Bing-Ze Lin; Shen-Ying Wan; Min-Ying Lin; Chih-Hsien Chang; Ting-Wen Chen; Muh-Hwa Yang; Yi-Jang Lee
Journal:  Molecules       Date:  2020-08-08       Impact factor: 4.411

9.  Profiling the lncRNA-miRNA-mRNA ceRNA network to reveal potential crosstalk between inflammatory bowel disease and colorectal cancer.

Authors:  Fangfang Sun; Weiwei Liang; Kejun Tang; Mengying Hong; Jing Qian
Journal:  PeerJ       Date:  2019-08-26       Impact factor: 2.984

10.  DPEP1 is a direct target of miR-193a-5p and promotes hepatoblastoma progression by PI3K/Akt/mTOR pathway.

Authors:  Xichun Cui; Xin Liu; Qicai Han; Jianming Zhu; Jianhao Li; Zhigang Ren; Liwen Liu; Yanbing Luo; Zhifang Wang; Dandan Zhang; Yingzhong Fan; Da Zhang; Gang Dong
Journal:  Cell Death Dis       Date:  2019-09-20       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.